Source: Health Canada shortage reports · Updated Jul 29, 2026
A shortage of Naloxone is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
A medicine used to rapidly reverse an opioid overdose.
Products affected
0 / 8
Reports on file
19
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
NALOXONE HYDROCHLORIDE INJECTION
0.4MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02393034 · Disruption of the manufacture of the drug.
Resolved
NALOXONE HYDROCHLORIDE INJECTION USP
0.4MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02382482 · ended Aug 7, 2025 · Hikma NALOXONE INJECTABLE (DIN 02458578, product code 0141AA01) available in same size ampoule and strength.
Resolved
NALOXONE HYDROCHLORIDE INJECTION
1MG · SOLUTION · OMEGA LABORATORIES LTD
DIN 02393042 · ended Jun 24, 2024 · Disruption of the manufacture of the drug.
Resolved
NALOXONE HYDROCHLORIDE INJECTION
0.4MG · SOLUTION · OMEGA LABORATORIES LTD
DIN 02393034 · ended Oct 14, 2024 · Disruption of the manufacture of the drug.
Resolved
NALOXONE HCL INJECTION - 1MG/ML USP
1MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 02148714 · ended Mar 20, 2023 · Demand increase for the drug.
Resolved
NALOXONE INJECTABLE
0.4MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02458578 · ended Dec 30, 2022 · Delay in shipping of the drug.
Resolved
NALOXONE HCL INJECTION - 1MG/ML USP
1MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 02148714 · ended Dec 28, 2022 · Disruption of the manufacture of the drug.
Resolved
NALOXONE HCL INJECTION - 0.4MG/ML USP
0.4MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 02148706 · ended Apr 5, 2022 · Disruption of the manufacture of the drug.
Resolved
INJECTABLE NALOXONE HYDROCHLORIDE
0.4MG · SOLUTION · OMEGA LABORATORIES LTD
DIN 02455935 · ended Sep 7, 2021 · Disruption of the manufacture of the drug.
Resolved
NALOXONE HCL INJECTION - 1MG/ML USP
1MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 02148714 · ended Feb 12, 2021 · Disruption of the manufacture of the drug.
Resolved
NALOXONE HCL INJECTION - 0.4MG/ML USP
0.4MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 02148706 · ended Jun 19, 2019 · Demand increase for the drug.
Resolved
S.O.S. NALOXONE HYDROCHLORIDE INJECTION
0.4MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02453258 · ended Jul 1, 2019 · Requirements related to complying with good manufacturing practices.
Showing 12 of 19 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Naloxone to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Naloxone is classified under “ALL OTHER THERAPEUTIC PRODUCTS” (ATC V03AB).
Recent changes
Jul 29, 2026
New report filed
Common questions
What is Naloxone used for?
A medicine used to rapidly reverse an opioid overdose.
When will Naloxone be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Naloxone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.